News and Announcements
AIMEDICS Controlled UK Release Has first HypoMon Users
- Published September 03, 2012 7:16PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
By: Lachlan Colquhoun
AIMEDICS today announced the first use of the HypoMon in the UK involving 2 young people with type 1 diabetes who have successfully used it during August 2012.
Victor Skladnev, AIMEDICS CEO said “We are very excited to have our first customers benefiting from the HypoMon in the UK. This is a critical step in AIMEDICS UK sales and marketing strategy to prove the value of the HypoMon to users and healthcare professionals.”
——
To view the full article, please click the link below.